With the CDC director's chair still empty, HHS Secretary Robert F. Kennedy Jr. endorsed recommendations made months ago by ...

The expanded recommendation is good news for Moderna, Pfizer, and GSK, which all sell RSV vaccines for older adults. Moderna ...

A newly configured federal vaccine panel's June 25 action is expected to improve options to protect infants from potentially ...

In April, the CDC’s influential Advisory Committee on Immunization Practices recommended expanding RSV vaccination to ...

The votes on vaccine recommendations are the first move by the panel after Health and Human Services Secretary Robert F.

The eight new ACIP members met for the first time June 25 after Kennedy fired all 17 original members of the committee June 9 ...

RFK Jr.’s vaccine panel endorsed Merck’s RSV shot for babies, easing fears that his stance might delay rollout.

The FDA delivered two notable approvals for RSV immunization, UroGen overcame a negative advisory committee vote to secure an ...

While RSV has yet to take off in an extraordinary way like it did in 2022, those who are looking to protect their children from the virus are running into a major problem: the much-hyped shot is ...

But the shot is hard to come by. RSV is a common respiratory virus that usually causes mild, cold-like symptoms in most adults who recover in a week or two, according to the Centers for Disease ...

A group of mothers in Victoria say they've experienced trouble accessing the jab for a highly infectious illness that infects ...

Hospitals were overwhelmed last winter by a surge in pediatric cases of RSV. Now a new monoclonal antibody shot could help, but price and supply issues are causing delays in getting it to infants.